La maladie de Parkinson en France (serveur d'exploration)

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Diagnostic procedures for Parkinson's disease dementia: Recommendations from the movement disorder society task force

Identifieur interne : 001A21 ( Istex/Corpus ); précédent : 001A20; suivant : 001A22

Diagnostic procedures for Parkinson's disease dementia: Recommendations from the movement disorder society task force

Auteurs : Bruno Dubois ; David Burn ; Christopher Goetz ; Dag Aarsland ; Richard G. Brown ; Gerald A. Broe ; Dennis Dickson ; Charles Duyckaerts ; Jefferey Cummings ; Serge Gauthier ; Amos Korczyn ; Andrew Lees ; Richard Levy ; Irene Litvan ; Yoshikuni Mizuno ; Ian G. Mckeith ; C. Warren Olanow ; Werner Poewe ; Cristina Sampaio ; Eduardo Tolosa ; Murat Emre

Source :

RBID : ISTEX:6E57B2447643E9AF227ECAC3B1DF8B327F449F2D

English descriptors

Abstract

A preceding article described the clinical features of Parkinson's disease dementia (PD‐D) and proposed clinical diagnostic criteria for “probable” and “possible” PD‐D. The main focus of this article is to operationalize the diagnosis of PD‐D and to propose pratical guidelines based on a two level process depending upon the clinical scenario and the expertise of the evaluator involved in the assessment. Level I is aimed primarily at the clinician with no particular expertise in neuropsychological methods, but who requires a simple, pragmatic set of tests that are not excessively time‐consuming. Level I can be used alone or in concert with Level II, which is more suitable when there is the need to specify the pattern and the severity on the dementia of PD‐D for clinical monitoring, research studies or pharmacological trials. Level II tests can also be proposed when the diagnosis of PD‐D remains uncertain or equivocal at the end of a Level I evaluation. Given the lack of evidence‐based standards for some tests when applied in this clinical context, we have tried to make practical and unambiguous recommendations, based upon the available literature and the collective experience of the Task Force. We accept, however, that further validation of certain tests and modifications in the recommended cut off values will be required through future studies. © 2007 Movement Disorder Society

Url:
DOI: 10.1002/mds.21844

Links to Exploration step

ISTEX:6E57B2447643E9AF227ECAC3B1DF8B327F449F2D

Le document en format XML

<record>
<TEI wicri:istexFullTextTei="biblStruct">
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">Diagnostic procedures for Parkinson's disease dementia: Recommendations from the movement disorder society task force</title>
<author>
<name sortKey="Dubois, Bruno" sort="Dubois, Bruno" uniqKey="Dubois B" first="Bruno" last="Dubois">Bruno Dubois</name>
<affiliation>
<mods:affiliation>INSERM‐UPMC UMRS 610, Federation of Neurology, AP‐HP, Salpêtrière Hospital; Université Paris6, Paris, France</mods:affiliation>
</affiliation>
<affiliation>
<mods:affiliation>Neurology Department and Inserm U610, Salpêtrière Hospital, 47 Bd de l'Hôpital, Paris 75013, France</mods:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Burn, David" sort="Burn, David" uniqKey="Burn D" first="David" last="Burn">David Burn</name>
<affiliation>
<mods:affiliation>Institute for Ageing and Health, Newcastle University, United Kingdom</mods:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Goetz, Christopher" sort="Goetz, Christopher" uniqKey="Goetz C" first="Christopher" last="Goetz">Christopher Goetz</name>
<affiliation>
<mods:affiliation>Department of Neurological Sciences, Rush University Medical Center, Chicago, Illinois, USA</mods:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Aarsland, Dag" sort="Aarsland, Dag" uniqKey="Aarsland D" first="Dag" last="Aarsland">Dag Aarsland</name>
<affiliation>
<mods:affiliation>Norwegian Centre for Movement Disorders, Stavanger University Hospital, Stavanger, Norway</mods:affiliation>
</affiliation>
<affiliation>
<mods:affiliation>School of Medicine, University of Bergen, Norway</mods:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Brown, Richard G" sort="Brown, Richard G" uniqKey="Brown R" first="Richard G." last="Brown">Richard G. Brown</name>
<affiliation>
<mods:affiliation>Department of Psychology, King's College, London, United Kingdom</mods:affiliation>
</affiliation>
<affiliation>
<mods:affiliation>MRC Centre for Neurodegeneration Research, Institute of Psychiatry, King's College, London, United Kingdom</mods:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Broe, Gerald A" sort="Broe, Gerald A" uniqKey="Broe G" first="Gerald A." last="Broe">Gerald A. Broe</name>
<affiliation>
<mods:affiliation>Ageing Research Centre, Prince of Wales Hospital, Randwick, New South Wales, Australia</mods:affiliation>
</affiliation>
<affiliation>
<mods:affiliation>Faculty of Medicine, Prince of Wales Medical Research Institute, University of New South Wales, Randwick, New South Wales, Australia</mods:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Dickson, Dennis" sort="Dickson, Dennis" uniqKey="Dickson D" first="Dennis" last="Dickson">Dennis Dickson</name>
<affiliation>
<mods:affiliation>Department of Neuroscience, Mayo Clinic College of Medicine, Jacksonville, Florida, USA</mods:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Duyckaerts, Charles" sort="Duyckaerts, Charles" uniqKey="Duyckaerts C" first="Charles" last="Duyckaerts">Charles Duyckaerts</name>
<affiliation>
<mods:affiliation>Neuropathology Laboratory, Salpetriere Hospital, Paris VI Pierre et Marie Curie University, Inserm U679, Paris, France</mods:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Cummings, Jefferey" sort="Cummings, Jefferey" uniqKey="Cummings J" first="Jefferey" last="Cummings">Jefferey Cummings</name>
<affiliation>
<mods:affiliation>Department of Neurology, David Geffen School of Medicine at UCLA, Los Angeles, California, USA</mods:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Gauthier, Serge" sort="Gauthier, Serge" uniqKey="Gauthier S" first="Serge" last="Gauthier">Serge Gauthier</name>
<affiliation>
<mods:affiliation>Alzheimer Disease and Related Disorders Unit, McGill Center for Studies in Aging, Montreal, Quebec, Canada</mods:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Korczyn, Amos" sort="Korczyn, Amos" uniqKey="Korczyn A" first="Amos" last="Korczyn">Amos Korczyn</name>
<affiliation>
<mods:affiliation>Department of Neurology, Tel‐Aviv University, Ramat ‐Aviv, Israel</mods:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Lees, Andrew" sort="Lees, Andrew" uniqKey="Lees A" first="Andrew" last="Lees">Andrew Lees</name>
<affiliation>
<mods:affiliation>Department of Neurology, The National Hospital for Neurology and Neurosurgery, Queen Square, London, United Kingdom</mods:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Levy, Richard" sort="Levy, Richard" uniqKey="Levy R" first="Richard" last="Levy">Richard Levy</name>
<affiliation>
<mods:affiliation>INSERM U610, Hôpital de la Salpêtrière & AP‐HP, Hôpital Saint Antoine, Service de Neurologie, Paris, France</mods:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Litvan, Irene" sort="Litvan, Irene" uniqKey="Litvan I" first="Irene" last="Litvan">Irene Litvan</name>
<affiliation>
<mods:affiliation>Movement Disorder Program, Department of Neurology, University of Louisville School of Medicine, Louisville, Kentucky, USA</mods:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Mizuno, Yoshikuni" sort="Mizuno, Yoshikuni" uniqKey="Mizuno Y" first="Yoshikuni" last="Mizuno">Yoshikuni Mizuno</name>
<affiliation>
<mods:affiliation>Department of Neurology, Research Institute for Diseases of Old Ages, Juntendo University School of Medicine, Bunkyo‐ku, Tokyo, Japan</mods:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Mckeith, Ian G" sort="Mckeith, Ian G" uniqKey="Mckeith I" first="Ian G." last="Mckeith">Ian G. Mckeith</name>
<affiliation>
<mods:affiliation>Institute for Ageing and Health, Newcastle University, Newcastle upon Tyne, United Kingdom</mods:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Olanow, C Warren" sort="Olanow, C Warren" uniqKey="Olanow C" first="C. Warren" last="Olanow">C. Warren Olanow</name>
<affiliation>
<mods:affiliation>Department of Neurology, Mount Sinai School of Medicine, New York, USA</mods:affiliation>
</affiliation>
<affiliation>
<mods:affiliation>Department of Neuroscience, Mount Sinai School of Medicine, New York, USA</mods:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Poewe, Werner" sort="Poewe, Werner" uniqKey="Poewe W" first="Werner" last="Poewe">Werner Poewe</name>
<affiliation>
<mods:affiliation>Department of Neurology, Medical University of Innsbruck, Innsbruck, Austria</mods:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Sampaio, Cristina" sort="Sampaio, Cristina" uniqKey="Sampaio C" first="Cristina" last="Sampaio">Cristina Sampaio</name>
<affiliation>
<mods:affiliation>Laboratorio de Farmacologia Clinica e Terapeutica, Faculdade de Medicina de Lisboa e Instituto de Medicina Molecular, Lisboa, Portugal</mods:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Tolosa, Eduardo" sort="Tolosa, Eduardo" uniqKey="Tolosa E" first="Eduardo" last="Tolosa">Eduardo Tolosa</name>
<affiliation>
<mods:affiliation>Parkinson's Disease and Movement Disorders Unit, Neurology Service, Institut Clinic de Neurociences, Hospital Clinic de Barcelona, IDIBAPS, Universitat de Barcelona, CIBERNED, Barcelona, Catalonia, Spain</mods:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Emre, Murat" sort="Emre, Murat" uniqKey="Emre M" first="Murat" last="Emre">Murat Emre</name>
<affiliation>
<mods:affiliation>Department of Neurology, Behavioral Neurology and Movement Disorders Unit, Ístanbul Faculty of Medicine, Ístanbul University, Ístanbul, Turkey</mods:affiliation>
</affiliation>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">ISTEX</idno>
<idno type="RBID">ISTEX:6E57B2447643E9AF227ECAC3B1DF8B327F449F2D</idno>
<date when="2007" year="2007">2007</date>
<idno type="doi">10.1002/mds.21844</idno>
<idno type="url">https://api.istex.fr/document/6E57B2447643E9AF227ECAC3B1DF8B327F449F2D/fulltext/pdf</idno>
<idno type="wicri:Area/Istex/Corpus">001A21</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">001A21</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title level="a" type="main" xml:lang="en">Diagnostic procedures for Parkinson's disease dementia: Recommendations from the movement disorder society task force</title>
<author>
<name sortKey="Dubois, Bruno" sort="Dubois, Bruno" uniqKey="Dubois B" first="Bruno" last="Dubois">Bruno Dubois</name>
<affiliation>
<mods:affiliation>INSERM‐UPMC UMRS 610, Federation of Neurology, AP‐HP, Salpêtrière Hospital; Université Paris6, Paris, France</mods:affiliation>
</affiliation>
<affiliation>
<mods:affiliation>Neurology Department and Inserm U610, Salpêtrière Hospital, 47 Bd de l'Hôpital, Paris 75013, France</mods:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Burn, David" sort="Burn, David" uniqKey="Burn D" first="David" last="Burn">David Burn</name>
<affiliation>
<mods:affiliation>Institute for Ageing and Health, Newcastle University, United Kingdom</mods:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Goetz, Christopher" sort="Goetz, Christopher" uniqKey="Goetz C" first="Christopher" last="Goetz">Christopher Goetz</name>
<affiliation>
<mods:affiliation>Department of Neurological Sciences, Rush University Medical Center, Chicago, Illinois, USA</mods:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Aarsland, Dag" sort="Aarsland, Dag" uniqKey="Aarsland D" first="Dag" last="Aarsland">Dag Aarsland</name>
<affiliation>
<mods:affiliation>Norwegian Centre for Movement Disorders, Stavanger University Hospital, Stavanger, Norway</mods:affiliation>
</affiliation>
<affiliation>
<mods:affiliation>School of Medicine, University of Bergen, Norway</mods:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Brown, Richard G" sort="Brown, Richard G" uniqKey="Brown R" first="Richard G." last="Brown">Richard G. Brown</name>
<affiliation>
<mods:affiliation>Department of Psychology, King's College, London, United Kingdom</mods:affiliation>
</affiliation>
<affiliation>
<mods:affiliation>MRC Centre for Neurodegeneration Research, Institute of Psychiatry, King's College, London, United Kingdom</mods:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Broe, Gerald A" sort="Broe, Gerald A" uniqKey="Broe G" first="Gerald A." last="Broe">Gerald A. Broe</name>
<affiliation>
<mods:affiliation>Ageing Research Centre, Prince of Wales Hospital, Randwick, New South Wales, Australia</mods:affiliation>
</affiliation>
<affiliation>
<mods:affiliation>Faculty of Medicine, Prince of Wales Medical Research Institute, University of New South Wales, Randwick, New South Wales, Australia</mods:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Dickson, Dennis" sort="Dickson, Dennis" uniqKey="Dickson D" first="Dennis" last="Dickson">Dennis Dickson</name>
<affiliation>
<mods:affiliation>Department of Neuroscience, Mayo Clinic College of Medicine, Jacksonville, Florida, USA</mods:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Duyckaerts, Charles" sort="Duyckaerts, Charles" uniqKey="Duyckaerts C" first="Charles" last="Duyckaerts">Charles Duyckaerts</name>
<affiliation>
<mods:affiliation>Neuropathology Laboratory, Salpetriere Hospital, Paris VI Pierre et Marie Curie University, Inserm U679, Paris, France</mods:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Cummings, Jefferey" sort="Cummings, Jefferey" uniqKey="Cummings J" first="Jefferey" last="Cummings">Jefferey Cummings</name>
<affiliation>
<mods:affiliation>Department of Neurology, David Geffen School of Medicine at UCLA, Los Angeles, California, USA</mods:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Gauthier, Serge" sort="Gauthier, Serge" uniqKey="Gauthier S" first="Serge" last="Gauthier">Serge Gauthier</name>
<affiliation>
<mods:affiliation>Alzheimer Disease and Related Disorders Unit, McGill Center for Studies in Aging, Montreal, Quebec, Canada</mods:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Korczyn, Amos" sort="Korczyn, Amos" uniqKey="Korczyn A" first="Amos" last="Korczyn">Amos Korczyn</name>
<affiliation>
<mods:affiliation>Department of Neurology, Tel‐Aviv University, Ramat ‐Aviv, Israel</mods:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Lees, Andrew" sort="Lees, Andrew" uniqKey="Lees A" first="Andrew" last="Lees">Andrew Lees</name>
<affiliation>
<mods:affiliation>Department of Neurology, The National Hospital for Neurology and Neurosurgery, Queen Square, London, United Kingdom</mods:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Levy, Richard" sort="Levy, Richard" uniqKey="Levy R" first="Richard" last="Levy">Richard Levy</name>
<affiliation>
<mods:affiliation>INSERM U610, Hôpital de la Salpêtrière & AP‐HP, Hôpital Saint Antoine, Service de Neurologie, Paris, France</mods:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Litvan, Irene" sort="Litvan, Irene" uniqKey="Litvan I" first="Irene" last="Litvan">Irene Litvan</name>
<affiliation>
<mods:affiliation>Movement Disorder Program, Department of Neurology, University of Louisville School of Medicine, Louisville, Kentucky, USA</mods:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Mizuno, Yoshikuni" sort="Mizuno, Yoshikuni" uniqKey="Mizuno Y" first="Yoshikuni" last="Mizuno">Yoshikuni Mizuno</name>
<affiliation>
<mods:affiliation>Department of Neurology, Research Institute for Diseases of Old Ages, Juntendo University School of Medicine, Bunkyo‐ku, Tokyo, Japan</mods:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Mckeith, Ian G" sort="Mckeith, Ian G" uniqKey="Mckeith I" first="Ian G." last="Mckeith">Ian G. Mckeith</name>
<affiliation>
<mods:affiliation>Institute for Ageing and Health, Newcastle University, Newcastle upon Tyne, United Kingdom</mods:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Olanow, C Warren" sort="Olanow, C Warren" uniqKey="Olanow C" first="C. Warren" last="Olanow">C. Warren Olanow</name>
<affiliation>
<mods:affiliation>Department of Neurology, Mount Sinai School of Medicine, New York, USA</mods:affiliation>
</affiliation>
<affiliation>
<mods:affiliation>Department of Neuroscience, Mount Sinai School of Medicine, New York, USA</mods:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Poewe, Werner" sort="Poewe, Werner" uniqKey="Poewe W" first="Werner" last="Poewe">Werner Poewe</name>
<affiliation>
<mods:affiliation>Department of Neurology, Medical University of Innsbruck, Innsbruck, Austria</mods:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Sampaio, Cristina" sort="Sampaio, Cristina" uniqKey="Sampaio C" first="Cristina" last="Sampaio">Cristina Sampaio</name>
<affiliation>
<mods:affiliation>Laboratorio de Farmacologia Clinica e Terapeutica, Faculdade de Medicina de Lisboa e Instituto de Medicina Molecular, Lisboa, Portugal</mods:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Tolosa, Eduardo" sort="Tolosa, Eduardo" uniqKey="Tolosa E" first="Eduardo" last="Tolosa">Eduardo Tolosa</name>
<affiliation>
<mods:affiliation>Parkinson's Disease and Movement Disorders Unit, Neurology Service, Institut Clinic de Neurociences, Hospital Clinic de Barcelona, IDIBAPS, Universitat de Barcelona, CIBERNED, Barcelona, Catalonia, Spain</mods:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Emre, Murat" sort="Emre, Murat" uniqKey="Emre M" first="Murat" last="Emre">Murat Emre</name>
<affiliation>
<mods:affiliation>Department of Neurology, Behavioral Neurology and Movement Disorders Unit, Ístanbul Faculty of Medicine, Ístanbul University, Ístanbul, Turkey</mods:affiliation>
</affiliation>
</author>
</analytic>
<monogr></monogr>
<series>
<title level="j">Movement Disorders</title>
<title level="j" type="abbrev">Mov. Disord.</title>
<idno type="ISSN">0885-3185</idno>
<idno type="eISSN">1531-8257</idno>
<imprint>
<publisher>Wiley Subscription Services, Inc., A Wiley Company</publisher>
<pubPlace>Hoboken</pubPlace>
<date type="published" when="2007-12-15">2007-12-15</date>
<biblScope unit="volume">22</biblScope>
<biblScope unit="issue">16</biblScope>
<biblScope unit="page" from="2314">2314</biblScope>
<biblScope unit="page" to="2324">2324</biblScope>
</imprint>
<idno type="ISSN">0885-3185</idno>
</series>
<idno type="istex">6E57B2447643E9AF227ECAC3B1DF8B327F449F2D</idno>
<idno type="DOI">10.1002/mds.21844</idno>
<idno type="ArticleID">MDS21844</idno>
</biblStruct>
</sourceDesc>
<seriesStmt>
<idno type="ISSN">0885-3185</idno>
</seriesStmt>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>PD dementia</term>
<term>Parkinson's disease</term>
<term>diagnostic criteria</term>
<term>executive functions</term>
<term>task force</term>
</keywords>
</textClass>
<langUsage>
<language ident="en">en</language>
</langUsage>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">A preceding article described the clinical features of Parkinson's disease dementia (PD‐D) and proposed clinical diagnostic criteria for “probable” and “possible” PD‐D. The main focus of this article is to operationalize the diagnosis of PD‐D and to propose pratical guidelines based on a two level process depending upon the clinical scenario and the expertise of the evaluator involved in the assessment. Level I is aimed primarily at the clinician with no particular expertise in neuropsychological methods, but who requires a simple, pragmatic set of tests that are not excessively time‐consuming. Level I can be used alone or in concert with Level II, which is more suitable when there is the need to specify the pattern and the severity on the dementia of PD‐D for clinical monitoring, research studies or pharmacological trials. Level II tests can also be proposed when the diagnosis of PD‐D remains uncertain or equivocal at the end of a Level I evaluation. Given the lack of evidence‐based standards for some tests when applied in this clinical context, we have tried to make practical and unambiguous recommendations, based upon the available literature and the collective experience of the Task Force. We accept, however, that further validation of certain tests and modifications in the recommended cut off values will be required through future studies. © 2007 Movement Disorder Society</div>
</front>
</TEI>
<istex>
<corpusName>wiley</corpusName>
<author>
<json:item>
<name>Bruno Dubois MD</name>
<affiliations>
<json:string>INSERM‐UPMC UMRS 610, Federation of Neurology, AP‐HP, Salpêtrière Hospital; Université Paris6, Paris, France</json:string>
<json:string>Neurology Department and Inserm U610, Salpêtrière Hospital, 47 Bd de l'Hôpital, Paris 75013, France</json:string>
</affiliations>
</json:item>
<json:item>
<name>David Burn MD</name>
<affiliations>
<json:string>Institute for Ageing and Health, Newcastle University, United Kingdom</json:string>
</affiliations>
</json:item>
<json:item>
<name>Christopher Goetz MD</name>
<affiliations>
<json:string>Department of Neurological Sciences, Rush University Medical Center, Chicago, Illinois, USA</json:string>
</affiliations>
</json:item>
<json:item>
<name>Dag Aarsland MD, PhD</name>
<affiliations>
<json:string>Norwegian Centre for Movement Disorders, Stavanger University Hospital, Stavanger, Norway</json:string>
<json:string>School of Medicine, University of Bergen, Norway</json:string>
</affiliations>
</json:item>
<json:item>
<name>Richard G. Brown PhD</name>
<affiliations>
<json:string>Department of Psychology, King's College, London, United Kingdom</json:string>
<json:string>MRC Centre for Neurodegeneration Research, Institute of Psychiatry, King's College, London, United Kingdom</json:string>
</affiliations>
</json:item>
<json:item>
<name>Gerald A. Broe HB, BS</name>
<affiliations>
<json:string>Ageing Research Centre, Prince of Wales Hospital, Randwick, New South Wales, Australia</json:string>
<json:string>Faculty of Medicine, Prince of Wales Medical Research Institute, University of New South Wales, Randwick, New South Wales, Australia</json:string>
</affiliations>
</json:item>
<json:item>
<name>Dennis Dickson MD</name>
<affiliations>
<json:string>Department of Neuroscience, Mayo Clinic College of Medicine, Jacksonville, Florida, USA</json:string>
</affiliations>
</json:item>
<json:item>
<name>Charles Duyckaerts MD, PhD</name>
<affiliations>
<json:string>Neuropathology Laboratory, Salpetriere Hospital, Paris VI Pierre et Marie Curie University, Inserm U679, Paris, France</json:string>
</affiliations>
</json:item>
<json:item>
<name>Jefferey Cummings MD</name>
<affiliations>
<json:string>Department of Neurology, David Geffen School of Medicine at UCLA, Los Angeles, California, USA</json:string>
</affiliations>
</json:item>
<json:item>
<name>Serge Gauthier MD</name>
<affiliations>
<json:string>Alzheimer Disease and Related Disorders Unit, McGill Center for Studies in Aging, Montreal, Quebec, Canada</json:string>
</affiliations>
</json:item>
<json:item>
<name>Amos Korczyn MD, MSc</name>
<affiliations>
<json:string>Department of Neurology, Tel‐Aviv University, Ramat ‐Aviv, Israel</json:string>
</affiliations>
</json:item>
<json:item>
<name>Andrew Lees FRCP</name>
<affiliations>
<json:string>Department of Neurology, The National Hospital for Neurology and Neurosurgery, Queen Square, London, United Kingdom</json:string>
</affiliations>
</json:item>
<json:item>
<name>Richard Levy MD, PhD</name>
<affiliations>
<json:string>INSERM U610, Hôpital de la Salpêtrière & AP‐HP, Hôpital Saint Antoine, Service de Neurologie, Paris, France</json:string>
</affiliations>
</json:item>
<json:item>
<name>Irene Litvan MD</name>
<affiliations>
<json:string>Movement Disorder Program, Department of Neurology, University of Louisville School of Medicine, Louisville, Kentucky, USA</json:string>
</affiliations>
</json:item>
<json:item>
<name>Yoshikuni Mizuno MD</name>
<affiliations>
<json:string>Department of Neurology, Research Institute for Diseases of Old Ages, Juntendo University School of Medicine, Bunkyo‐ku, Tokyo, Japan</json:string>
</affiliations>
</json:item>
<json:item>
<name>Ian G. McKeith MD</name>
<affiliations>
<json:string>Institute for Ageing and Health, Newcastle University, Newcastle upon Tyne, United Kingdom</json:string>
</affiliations>
</json:item>
<json:item>
<name>C. Warren Olanow MD</name>
<affiliations>
<json:string>Department of Neurology, Mount Sinai School of Medicine, New York, USA</json:string>
<json:string>Department of Neuroscience, Mount Sinai School of Medicine, New York, USA</json:string>
</affiliations>
</json:item>
<json:item>
<name>Werner Poewe MD</name>
<affiliations>
<json:string>Department of Neurology, Medical University of Innsbruck, Innsbruck, Austria</json:string>
</affiliations>
</json:item>
<json:item>
<name>Cristina Sampaio MD, PhD</name>
<affiliations>
<json:string>Laboratorio de Farmacologia Clinica e Terapeutica, Faculdade de Medicina de Lisboa e Instituto de Medicina Molecular, Lisboa, Portugal</json:string>
</affiliations>
</json:item>
<json:item>
<name>Eduardo Tolosa MD</name>
<affiliations>
<json:string>Parkinson's Disease and Movement Disorders Unit, Neurology Service, Institut Clinic de Neurociences, Hospital Clinic de Barcelona, IDIBAPS, Universitat de Barcelona, CIBERNED, Barcelona, Catalonia, Spain</json:string>
</affiliations>
</json:item>
<json:item>
<name>Murat Emre MD</name>
<affiliations>
<json:string>Department of Neurology, Behavioral Neurology and Movement Disorders Unit, Ístanbul Faculty of Medicine, Ístanbul University, Ístanbul, Turkey</json:string>
</affiliations>
</json:item>
</author>
<subject>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>Parkinson's disease</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>PD dementia</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>diagnostic criteria</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>executive functions</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>task force</value>
</json:item>
</subject>
<articleId>
<json:string>MDS21844</json:string>
</articleId>
<language>
<json:string>eng</json:string>
</language>
<originalGenre>
<json:string>reviewArticle</json:string>
</originalGenre>
<abstract>A preceding article described the clinical features of Parkinson's disease dementia (PD‐D) and proposed clinical diagnostic criteria for “probable” and “possible” PD‐D. The main focus of this article is to operationalize the diagnosis of PD‐D and to propose pratical guidelines based on a two level process depending upon the clinical scenario and the expertise of the evaluator involved in the assessment. Level I is aimed primarily at the clinician with no particular expertise in neuropsychological methods, but who requires a simple, pragmatic set of tests that are not excessively time‐consuming. Level I can be used alone or in concert with Level II, which is more suitable when there is the need to specify the pattern and the severity on the dementia of PD‐D for clinical monitoring, research studies or pharmacological trials. Level II tests can also be proposed when the diagnosis of PD‐D remains uncertain or equivocal at the end of a Level I evaluation. Given the lack of evidence‐based standards for some tests when applied in this clinical context, we have tried to make practical and unambiguous recommendations, based upon the available literature and the collective experience of the Task Force. We accept, however, that further validation of certain tests and modifications in the recommended cut off values will be required through future studies. © 2007 Movement Disorder Society</abstract>
<qualityIndicators>
<score>7.64</score>
<pdfVersion>1.3</pdfVersion>
<pdfPageSize>594 x 792 pts</pdfPageSize>
<refBibsNative>true</refBibsNative>
<abstractCharCount>1399</abstractCharCount>
<pdfWordCount>7054</pdfWordCount>
<pdfCharCount>45141</pdfCharCount>
<pdfPageCount>11</pdfPageCount>
<abstractWordCount>220</abstractWordCount>
</qualityIndicators>
<title>Diagnostic procedures for Parkinson's disease dementia: Recommendations from the movement disorder society task force</title>
<refBibs>
<json:item>
<author>
<json:item>
<name>M Emre</name>
</json:item>
<json:item>
<name>D Aarsland</name>
</json:item>
<json:item>
<name>R Brown</name>
</json:item>
</author>
<host>
<volume>22</volume>
<pages>
<last>1707</last>
<first>1689</first>
</pages>
<author></author>
<title>Mov Disord</title>
</host>
<title>Clinical diagnostic criteria for dementia associated with Parkinson disease</title>
</json:item>
<json:item>
<author>
<json:item>
<name>AJ Hughes</name>
</json:item>
<json:item>
<name>SE Daniel</name>
</json:item>
<json:item>
<name>S Blankson</name>
</json:item>
<json:item>
<name>AJ Lees</name>
</json:item>
</author>
<host>
<volume>50</volume>
<pages>
<last>148</last>
<first>140</first>
</pages>
<author></author>
<title>Arch Neurol</title>
</host>
<title>A clinicopathologic study of 100 cases of Parkinson's disease</title>
</json:item>
<json:item>
<author>
<json:item>
<name>MF Folstein</name>
</json:item>
<json:item>
<name>SE Folstein</name>
</json:item>
<json:item>
<name>PR McHugh</name>
</json:item>
</author>
<host>
<volume>12</volume>
<pages>
<last>198</last>
<first>189</first>
</pages>
<author></author>
<title>J Psychiatr Res</title>
</host>
<title>“Mini‐mental state.” A practical method for grading the cognitive state of patients for the clinician</title>
</json:item>
<json:item>
<author>
<json:item>
<name>M Emre</name>
</json:item>
<json:item>
<name>D Aarsland</name>
</json:item>
<json:item>
<name>A Albanese</name>
</json:item>
</author>
<host>
<volume>351</volume>
<pages>
<last>2518</last>
<first>2509</first>
</pages>
<author></author>
<title>N Engl J Med</title>
</host>
<title>Rivastigmine for dementia associated with Parkinson's disease</title>
</json:item>
<json:item>
<host>
<author></author>
<title>Efficacy and safety of donepezil in the treatment of Parkinson's disease patients with dementia</title>
</host>
</json:item>
<json:item>
<author>
<json:item>
<name>RM Crum</name>
</json:item>
<json:item>
<name>JC Anthony</name>
</json:item>
<json:item>
<name>SS Bassett</name>
</json:item>
<json:item>
<name>MF Folstein</name>
</json:item>
</author>
<host>
<volume>269</volume>
<pages>
<last>2391</last>
<first>2386</first>
</pages>
<author></author>
<title>JAMA</title>
</host>
<title>Population‐based norms for the Mini‐Mental State Examination by age and educational level</title>
</json:item>
<json:item>
<author>
<json:item>
<name>C Dufouil</name>
</json:item>
<json:item>
<name>D Clayton</name>
</json:item>
<json:item>
<name>C Brayne</name>
</json:item>
</author>
<host>
<volume>55</volume>
<pages>
<last>1613</last>
<first>1609</first>
</pages>
<author></author>
<title>Neurology</title>
</host>
<title>Population norms for the MMSE in the very old: estimates based on longitudinal data. Mini‐Mental State Examination</title>
</json:item>
<json:item>
<host>
<author></author>
<title>American Psychiatric Association.Diagnostic and stastical manual of mental disordes (IV‐TR),4th ed. (Text Revised).Washington, DC:American Psychiatric Association;2000.</title>
</host>
</json:item>
<json:item>
<author>
<json:item>
<name>DHK Shum</name>
</json:item>
<json:item>
<name>KA McFarland</name>
</json:item>
<json:item>
<name>JD Bain</name>
</json:item>
</author>
<host>
<volume>4</volume>
<pages>
<last>162</last>
<first>151</first>
</pages>
<author></author>
<title>Clin Neuropsychol</title>
</host>
<title>Construct validity of eight tests of attention: comparison of normal and closed head injury samples</title>
</json:item>
<json:item>
<host>
<author></author>
<title>Benton AL,Hamsher KD.Multilingual aphasia examination.Iowa City, Iowa:AJA Associates;1989.</title>
</host>
</json:item>
<json:item>
<author>
<json:item>
<name>DM Jacobs</name>
</json:item>
<json:item>
<name>K Marder</name>
</json:item>
<json:item>
<name>LJ Cote</name>
</json:item>
<json:item>
<name>M Sano</name>
</json:item>
<json:item>
<name>Y Stern</name>
</json:item>
<json:item>
<name>R Mayeux</name>
</json:item>
</author>
<host>
<volume>45</volume>
<pages>
<last>1696</last>
<first>1691</first>
</pages>
<author></author>
<title>Neurology</title>
</host>
<title>Neuropsychological characteristics of preclinical dementia in Parkinson's disease</title>
</json:item>
<json:item>
<author>
<json:item>
<name>G Levy</name>
</json:item>
<json:item>
<name>DM Jacobs</name>
</json:item>
<json:item>
<name>MX Tang</name>
</json:item>
</author>
<host>
<volume>17</volume>
<pages>
<last>1226</last>
<first>1221</first>
</pages>
<author></author>
<title>Mov Disord</title>
</host>
<title>Memory and executive function impairment predict dementia in Parkinson's disease</title>
</json:item>
<json:item>
<author>
<json:item>
<name>B Dubois</name>
</json:item>
<json:item>
<name>A Slachevsky</name>
</json:item>
<json:item>
<name>I Litvan</name>
</json:item>
<json:item>
<name>B Pillon</name>
</json:item>
</author>
<host>
<volume>55</volume>
<pages>
<last>1626</last>
<first>1621</first>
</pages>
<author></author>
<title>Neurology</title>
</host>
<title>The FAB: a Frontal Assessment Battery at bedside</title>
</json:item>
<json:item>
<author>
<json:item>
<name>T Sunderland</name>
</json:item>
<json:item>
<name>JL Hill</name>
</json:item>
<json:item>
<name>AM Mellow</name>
</json:item>
</author>
<host>
<volume>37</volume>
<pages>
<last>729</last>
<first>725</first>
</pages>
<author></author>
<title>J Am Geriatr Soc</title>
</host>
<title>Clock drawing in Alzheimer's disease</title>
</json:item>
<json:item>
<author>
<json:item>
<name>B Pillon</name>
</json:item>
<json:item>
<name>B Deweer</name>
</json:item>
<json:item>
<name>Y Agid</name>
</json:item>
<json:item>
<name>B Dubois</name>
</json:item>
</author>
<host>
<volume>50</volume>
<pages>
<last>379</last>
<first>374</first>
</pages>
<author></author>
<title>Arch Neurol</title>
</host>
<title>Explicit memory in Alzheimer's, Huntington's, and Parkinson's diseases</title>
</json:item>
<json:item>
<author>
<json:item>
<name>K Bronnick</name>
</json:item>
<json:item>
<name>D Aarsland</name>
</json:item>
<json:item>
<name>JP Larsen</name>
</json:item>
</author>
<host>
<volume>112</volume>
<pages>
<last>207</last>
<first>201</first>
</pages>
<author></author>
<title>Acta Psychiatr Scand</title>
</host>
<title>Neuropsychiatric disturbances in Parkinson's disease clusters in five groups with different prevalence of dementia</title>
</json:item>
<json:item>
<author>
<json:item>
<name>IG McKeith</name>
</json:item>
<json:item>
<name>DW Dickson</name>
</json:item>
<json:item>
<name>J Lowe</name>
</json:item>
</author>
<host>
<volume>65</volume>
<pages>
<last>1872</last>
<first>1863</first>
</pages>
<author></author>
<title>Neurology</title>
</host>
<title>Diagnosis and management of dementia with Lewy bodies: third report of the DLB Consortium</title>
</json:item>
<json:item>
<author>
<json:item>
<name>OP Almeida</name>
</json:item>
<json:item>
<name>SA Almeida</name>
</json:item>
</author>
<host>
<volume>14</volume>
<pages>
<last>865</last>
<first>858</first>
</pages>
<author></author>
<title>Int J Geriatr Psychiatry</title>
</host>
<title>Short versions of the geriatric depression scale: a study of their validity for the diagnosis of a major depressive episode according to ICD‐10 and DSM‐IV</title>
</json:item>
<json:item>
<author>
<json:item>
<name>D Weintraub</name>
</json:item>
<json:item>
<name>KA Oehlberg</name>
</json:item>
<json:item>
<name>IR Katz</name>
</json:item>
<json:item>
<name>MB Stern</name>
</json:item>
</author>
<host>
<volume>14</volume>
<pages>
<last>175</last>
<first>169</first>
</pages>
<author></author>
<title>Am J Geriatr Psychiatry</title>
</host>
<title>Test characteristic of the 15‐item geriatric depression scale and Hamilton depression rating scale in Parkinson's disease</title>
</json:item>
<json:item>
<host>
<author></author>
<title>Mattis S.Dementia Rating Scale.Odessa, FL:Psychological Assessment Resources;1988.</title>
</host>
</json:item>
<json:item>
<author>
<json:item>
<name>B Pillon</name>
</json:item>
<json:item>
<name>F Boller</name>
</json:item>
<json:item>
<name>R Levy</name>
</json:item>
<json:item>
<name>B Dubois</name>
</json:item>
</author>
<host>
<volume>6</volume>
<pages>
<last>371</last>
<first>311</first>
</pages>
<author></author>
<title>Handbook of neuropsychology</title>
</host>
<title>Cognitive deficits and dementia in Parkinson's disease</title>
</json:item>
<json:item>
<author>
<json:item>
<name>GE Smith</name>
</json:item>
<json:item>
<name>RJ Ivnik</name>
</json:item>
<json:item>
<name>JF Malec</name>
</json:item>
<json:item>
<name>E Kokmen</name>
</json:item>
<json:item>
<name>E Tangolos</name>
</json:item>
<json:item>
<name>RC Petersen</name>
</json:item>
</author>
<host>
<volume>1</volume>
<pages>
<last>132</last>
<first>123</first>
</pages>
<author></author>
<title>Assessment</title>
</host>
<title>Psychometric properties of the Mattis Dementia Rating Scale</title>
</json:item>
<json:item>
<author>
<json:item>
<name>JA Lucas</name>
</json:item>
<json:item>
<name>RJ Ivnik</name>
</json:item>
<json:item>
<name>GE Smith</name>
</json:item>
</author>
<host>
<volume>20</volume>
<pages>
<last>547</last>
<first>536</first>
</pages>
<author></author>
<title>J Clin Exp Neuropsychol</title>
</host>
<title>Normative date for the Mattis Dementia Rating Scale</title>
</json:item>
<json:item>
<author>
<json:item>
<name>B Dubois</name>
</json:item>
<json:item>
<name>R Levy</name>
</json:item>
</author>
<host>
<volume>16</volume>
<pages>
<last>4387</last>
<first>4379</first>
</pages>
<author></author>
<title>Int Psychogeriatr</title>
</host>
<title>Cognition, behavior and the frontal lobes</title>
</json:item>
<json:item>
<host>
<author></author>
<title>Wechsler D.Wechsler Memory Scale,3rd ed.San Antonio, TX:The Psychological Corporation;1997.</title>
</host>
</json:item>
<json:item>
<author>
<json:item>
<name>GA Miller</name>
</json:item>
</author>
<host>
<volume>63</volume>
<pages>
<last>97</last>
<first>81</first>
</pages>
<author></author>
<title>Psychol Rev</title>
</host>
<title>The magical number seven, plus or minus two: some limits on our capacity for processing information</title>
</json:item>
<json:item>
<author>
<json:item>
<name>HH Spitz</name>
</json:item>
</author>
<host>
<volume>78</volume>
<pages>
<last>185</last>
<first>183</first>
</pages>
<author></author>
<title>Psychol Bull</title>
</host>
<title>Note on immediate memory for digits: invariance over the years</title>
</json:item>
<json:item>
<author>
<json:item>
<name>SP Woods</name>
</json:item>
<json:item>
<name>AI Tröster</name>
</json:item>
</author>
<host>
<volume>9</volume>
<pages>
<last>24</last>
<first>17</first>
</pages>
<author></author>
<title>J Int Neuropsychol Soc</title>
</host>
<title>Prodromal frontal/executive dysfunction predicts incident dementia in Parkinson's disease</title>
</json:item>
<json:item>
<author>
<json:item>
<name>AM Owen</name>
</json:item>
<json:item>
<name>M Beksinska</name>
</json:item>
<json:item>
<name>M James</name>
</json:item>
</author>
<host>
<volume>31</volume>
<pages>
<last>644</last>
<first>627</first>
</pages>
<author></author>
<title>Neuropsychologia</title>
</host>
<title>Visuospatial memory deficits at different stages of Parkinson's disease</title>
</json:item>
<json:item>
<author>
<json:item>
<name>B Milner</name>
</json:item>
</author>
<host>
<volume>27</volume>
<pages>
<last>277</last>
<first>272</first>
</pages>
<author></author>
<title>Br Med Bull</title>
</host>
<title>Interhemispheric differences in the localization of psychological processes in man</title>
</json:item>
<json:item>
<author>
<json:item>
<name>M Richards</name>
</json:item>
<json:item>
<name>LJ Cote</name>
</json:item>
<json:item>
<name>Y Stern</name>
</json:item>
</author>
<host>
<volume>15</volume>
<pages>
<last>279</last>
<first>266</first>
</pages>
<author></author>
<title>J Clin Exp Neuropsychol</title>
</host>
<title>Executive function in Parkinson's disease: set‐shifting or set‐maintenance?</title>
</json:item>
<json:item>
<author>
<json:item>
<name>JA Cooper</name>
</json:item>
<json:item>
<name>HJ Sagar</name>
</json:item>
<json:item>
<name>N Jordan</name>
</json:item>
<json:item>
<name>NS Harvey</name>
</json:item>
<json:item>
<name>EV Sullivan</name>
</json:item>
</author>
<host>
<volume>114</volume>
<pages>
<last>2122</last>
<first>2095</first>
</pages>
<issue>Part 5</issue>
<author></author>
<title>Brain</title>
</host>
<title>Cognitive impairment in early, untreated Parkinson's disease and its relationship to motor disability</title>
</json:item>
<json:item>
<author>
<json:item>
<name>CD Hoppe</name>
</json:item>
<json:item>
<name>UD Müller</name>
</json:item>
<json:item>
<name>KD Werheid</name>
</json:item>
<json:item>
<name>AD Thöne</name>
</json:item>
<json:item>
<name>YD von Cramon</name>
</json:item>
</author>
<host>
<volume>14</volume>
<pages>
<last>55</last>
<first>38</first>
</pages>
<author></author>
<title>Clin Neuropsychol</title>
</host>
<title>Digit Ordering Test: clinical, psychometric, and experimental evaluation of a verbal working memory test</title>
</json:item>
<json:item>
<host>
<author></author>
<title>Wechsler D.Wechsler Adult Intelligence Scale (WAIS‐3R),3rd ed.San Antonio, TX:Harcourt Assessment;1997.</title>
</host>
</json:item>
<json:item>
<author>
<json:item>
<name>B Milner</name>
</json:item>
</author>
<host>
<volume>9</volume>
<pages>
<last>100</last>
<first>90</first>
</pages>
<author></author>
<title>Archiv Neurol</title>
</host>
<title>Effects of different brain lesions on card sorting: the role of the frontal lobes</title>
</json:item>
<json:item>
<author>
<json:item>
<name>HE Nelson</name>
</json:item>
</author>
<host>
<volume>12</volume>
<pages>
<last>324</last>
<first>313</first>
</pages>
<author></author>
<title>Cortex</title>
</host>
<title>Modified card sorting test sensitive to frontal lobe defects</title>
</json:item>
<json:item>
<author>
<json:item>
<name>I Litvan</name>
</json:item>
<json:item>
<name>E Mohr</name>
</json:item>
<json:item>
<name>J Williams</name>
</json:item>
<json:item>
<name>C Gomez</name>
</json:item>
<json:item>
<name>TN Chase</name>
</json:item>
</author>
<host>
<volume>54</volume>
<pages>
<last>29</last>
<first>25</first>
</pages>
<author></author>
<title>J Neurol Neurosurg Psychiatry</title>
</host>
<title>Differential memory and executive functions in demented patients with Parkinson's and Alzheimer's disease</title>
</json:item>
<json:item>
<author>
<json:item>
<name>B Pillon</name>
</json:item>
<json:item>
<name>B Dubois</name>
</json:item>
<json:item>
<name>A Ploska</name>
</json:item>
<json:item>
<name>Y Agid</name>
</json:item>
</author>
<host>
<volume>41</volume>
<pages>
<last>643</last>
<first>634</first>
</pages>
<author></author>
<title>Neurology</title>
</host>
<title>Severity and specificity of cognitive impairment in Alzheimer's, Huntington's, and Parkinson's diseases and progressive supranuclear palsy</title>
</json:item>
<json:item>
<author>
<json:item>
<name>J Green</name>
</json:item>
<json:item>
<name>WM McDonald</name>
</json:item>
<json:item>
<name>JL Vitek</name>
</json:item>
</author>
<host>
<volume>59</volume>
<pages>
<last>1324</last>
<first>1320</first>
</pages>
<author></author>
<title>Neurology</title>
</host>
<title>Cognitive impairments in advanced PD without dementia</title>
</json:item>
<json:item>
<author>
<json:item>
<name>RM Reitan</name>
</json:item>
</author>
<host>
<volume>8</volume>
<pages>
<last>276</last>
<first>271</first>
</pages>
<author></author>
<title>Percept Mot Skills</title>
</host>
<title>Validity of the trail making test as an indication of organic brain damage</title>
</json:item>
<json:item>
<author>
<json:item>
<name>M Hietanen</name>
</json:item>
<json:item>
<name>H Teräväinen</name>
</json:item>
</author>
<host>
<volume>73</volume>
<pages>
<last>159</last>
<first>151</first>
</pages>
<author></author>
<title>Acta Neurol Scand</title>
</host>
<title>Cognitive performance in early Parkinson's disease</title>
</json:item>
<json:item>
<author>
<json:item>
<name>JR Stroop</name>
</json:item>
</author>
<host>
<volume>18</volume>
<pages>
<last>662</last>
<first>643</first>
</pages>
<author></author>
<title>J Exp Psychol</title>
</host>
<title>Studies of interference in serial verbal reactions</title>
</json:item>
<json:item>
<author>
<json:item>
<name>KA Flowers</name>
</json:item>
<json:item>
<name>C Robertson</name>
</json:item>
</author>
<host>
<volume>48</volume>
<pages>
<last>529</last>
<first>517</first>
</pages>
<author></author>
<title>J Neurol Neurosurg Psychiatry</title>
</host>
<title>The effect of Parkinson's disease on the ability to maintain a mental set</title>
</json:item>
<json:item>
<author>
<json:item>
<name>F Lhermitte</name>
</json:item>
<json:item>
<name>B Pillon</name>
</json:item>
<json:item>
<name>M Serdaru</name>
</json:item>
</author>
<host>
<volume>19</volume>
<pages>
<last>334</last>
<first>326</first>
</pages>
<author></author>
<title>Ann Neurol</title>
</host>
<title>Human autonomy and the frontal lobes, Part 1: Imitation and utilization behaviors: a neuropsychological study of 75 patients</title>
</json:item>
<json:item>
<author>
<json:item>
<name>B Dubois</name>
</json:item>
<json:item>
<name>A Slachevsky</name>
</json:item>
<json:item>
<name>I Litvan</name>
</json:item>
<json:item>
<name>B Pillon</name>
</json:item>
</author>
<host>
<volume>55</volume>
<pages>
<last>1626</last>
<first>1621</first>
</pages>
<author></author>
<title>Neurology</title>
</host>
<title>The FAB: a Frontal Assessment Battery at bedside</title>
</json:item>
<json:item>
<author>
<json:item>
<name>R Levy</name>
</json:item>
<json:item>
<name>B Dubois</name>
</json:item>
</author>
<host>
<volume>16</volume>
<pages>
<last>928</last>
<first>916</first>
</pages>
<author></author>
<title>Cereb Cortex</title>
</host>
<title>Apathy and the functional anatomy of the prefrontal cortex‐basal ganglia circuits</title>
</json:item>
<json:item>
<author>
<json:item>
<name>SE Starkstein</name>
</json:item>
<json:item>
<name>HS Mayberg</name>
</json:item>
<json:item>
<name>TJ Preziosi</name>
</json:item>
<json:item>
<name>P Andrezejewski</name>
</json:item>
<json:item>
<name>R Leiguarda</name>
</json:item>
<json:item>
<name>RG Robinson</name>
</json:item>
</author>
<host>
<volume>4</volume>
<pages>
<last>139</last>
<first>134</first>
</pages>
<author></author>
<title>J Neuropsychiatry Clin Neurosci</title>
</host>
<title>Reliability, validity, and clinical correlates of apathy in Parkinson's disease</title>
</json:item>
<json:item>
<author>
<json:item>
<name>RS Marin</name>
</json:item>
</author>
<host>
<volume>1</volume>
<pages>
<last>314</last>
<first>304</first>
</pages>
<author></author>
<title>Semin Clin Neuropsychiatry</title>
</host>
<title>Apathy: concept, syndrome, neural mechanisms and treatment</title>
</json:item>
<json:item>
<author>
<json:item>
<name>SE Starkstein</name>
</json:item>
<json:item>
<name>L Sabe</name>
</json:item>
<json:item>
<name>G Petracca</name>
</json:item>
</author>
<host>
<volume>61</volume>
<pages>
<last>387</last>
<first>381</first>
</pages>
<author></author>
<title>J Neurol Neurosurg Psychiatry</title>
</host>
<title>Neuropsychological and psychiatric differences between Alzheimer's disease and Parkinson's disease with dementia</title>
</json:item>
<json:item>
<author>
<json:item>
<name>JL Cummings</name>
</json:item>
<json:item>
<name>M Mega</name>
</json:item>
<json:item>
<name>K Gray</name>
</json:item>
<json:item>
<name>S Rosenberg‐Thompson</name>
</json:item>
<json:item>
<name>DA Carusi</name>
</json:item>
<json:item>
<name>J Gornbein</name>
</json:item>
</author>
<host>
<volume>44</volume>
<pages>
<last>2314</last>
<first>2308</first>
</pages>
<author></author>
<title>Neurology</title>
</host>
<title>The Neuropsychiatric Inventory: comprehensive assessment of psychopathology in dementia</title>
</json:item>
<json:item>
<author>
<json:item>
<name>JL Cummings</name>
</json:item>
</author>
<host>
<volume>48</volume>
<pages>
<last>16</last>
<first>10</first>
</pages>
<issue>5 Suppl 6</issue>
<author></author>
<title>Neurology</title>
</host>
<title>The Neuropsychiatric Inventory: assessing psychopathology in dementia patients</title>
</json:item>
<json:item>
<author>
<json:item>
<name>D Aarsland</name>
</json:item>
<json:item>
<name>JL Cummings</name>
</json:item>
<json:item>
<name>JP Larsen</name>
</json:item>
</author>
<host>
<volume>16</volume>
<pages>
<last>191</last>
<first>184</first>
</pages>
<author></author>
<title>Int J Geriatr Psychiatry</title>
</host>
<title>Neuropsychiatric differences between Parkinson's disease with dementia and Alzheimer's disease</title>
</json:item>
<json:item>
<host>
<author></author>
<title>Schmidt, M.Rey Auditory and Verbal Learning Test: a handbook.Los Angeles, CA:Western Psychological Services;1996.</title>
</host>
</json:item>
<json:item>
<author>
<json:item>
<name>E Grober</name>
</json:item>
<json:item>
<name>H Buschke</name>
</json:item>
</author>
<host>
<volume>3</volume>
<pages>
<last>36</last>
<first>13</first>
</pages>
<author></author>
<title>Dev Neuropsychol</title>
</host>
<title>Genuine memory deficits in dementia</title>
</json:item>
<json:item>
<author>
<json:item>
<name>MC Tierney</name>
</json:item>
<json:item>
<name>A Nores</name>
</json:item>
<json:item>
<name>WG Snow</name>
</json:item>
<json:item>
<name>RH Fisher</name>
</json:item>
<json:item>
<name>ML Zorzitto</name>
</json:item>
<json:item>
<name>DW Reid</name>
</json:item>
</author>
<host>
<volume>6</volume>
<pages>
<last>134</last>
<first>129</first>
</pages>
<author></author>
<title>Psychol Assess</title>
</host>
<title>Use of the Rey Auditory Verbal Learning Test in differentiating normal aging form Alzheimer's and Parkinson's dementia</title>
</json:item>
<json:item>
<author>
<json:item>
<name>JL Cummings</name>
</json:item>
<json:item>
<name>A Darkins</name>
</json:item>
<json:item>
<name>M Mendez</name>
</json:item>
<json:item>
<name>MA Hill</name>
</json:item>
<json:item>
<name>DF Benson</name>
</json:item>
</author>
<host>
<volume>38</volume>
<pages>
<last>684</last>
<first>680</first>
</pages>
<author></author>
<title>Neurology</title>
</host>
<title>Alzheimer's disease and Parkinson's disease: comparison of speech and language alterations</title>
</json:item>
<json:item>
<host>
<author></author>
<title>Kaplan EF,Goodglass H,Weintraub S.The Boston Naming Test,2nd ed.Philadelphia:Lea and Febiger;1983.</title>
</host>
</json:item>
<json:item>
<author>
<json:item>
<name>JC Borod</name>
</json:item>
<json:item>
<name>H Goodglass</name>
</json:item>
<json:item>
<name>E Kaplan</name>
</json:item>
</author>
<host>
<volume>2</volume>
<pages>
<last>216</last>
<first>209</first>
</pages>
<author></author>
<title>J Clin Neuropsychol</title>
</host>
<title>Normative date on the Boston Diagnostic Aphasia Examination, parietal lobe battery, and the Boston Naming Test</title>
</json:item>
<json:item>
<author>
<json:item>
<name>UP Mosimann</name>
</json:item>
<json:item>
<name>G Mather</name>
</json:item>
<json:item>
<name>KA Wesnes</name>
</json:item>
<json:item>
<name>JT O'Brien</name>
</json:item>
<json:item>
<name>DJ Burn</name>
</json:item>
<json:item>
<name>IG McKeith</name>
</json:item>
</author>
<host>
<volume>63</volume>
<pages>
<last>2096</last>
<first>2091</first>
</pages>
<author></author>
<title>Neurology</title>
</host>
<title>Visual perception in Parkinson disease dementia and dementia with Lewy bodies</title>
</json:item>
<json:item>
<author>
<json:item>
<name>C Janvin</name>
</json:item>
<json:item>
<name>D Aarsland</name>
</json:item>
<json:item>
<name>JP Larsen</name>
</json:item>
<json:item>
<name>K Hugdahl</name>
</json:item>
</author>
<host>
<volume>15</volume>
<pages>
<last>131</last>
<first>126</first>
</pages>
<author></author>
<title>Dement Geriatr Cogn Disord</title>
</host>
<title>Neuropsychological profile of patients with Parkinson's disease without dementia</title>
</json:item>
<json:item>
<host>
<author></author>
<title>Warrington EK,James M.The visual object and space perception battery.Bury St. Edmunds:Thames Valley Test Company;1991.</title>
</host>
</json:item>
<json:item>
<author>
<json:item>
<name>J Calderon</name>
</json:item>
<json:item>
<name>RJ Perry</name>
</json:item>
<json:item>
<name>SW Erzinclioglu</name>
</json:item>
<json:item>
<name>GE Berrios</name>
</json:item>
<json:item>
<name>TR Dening</name>
</json:item>
<json:item>
<name>JR Hodges</name>
</json:item>
</author>
<host>
<volume>70</volume>
<pages>
<last>164</last>
<first>157</first>
</pages>
<author></author>
<title>J Neurol Neurosurg Psychiatry</title>
</host>
<title>Perception, attention, and working memory are disproportionately impaired in dementia with Lewy bodies compared with Alzheimer's disease</title>
</json:item>
<json:item>
<author>
<json:item>
<name>AL Benton</name>
</json:item>
<json:item>
<name>PJ Eslinger</name>
</json:item>
<json:item>
<name>AR Damasio</name>
</json:item>
</author>
<host>
<volume>3</volume>
<pages>
<last>42</last>
<first>33</first>
</pages>
<author></author>
<title>J Clin Neuropsychol</title>
</host>
<title>Normative observations on neuropsychological test performances in old age</title>
</json:item>
<json:item>
<author>
<json:item>
<name>D Aarsland</name>
</json:item>
<json:item>
<name>K Bronnick</name>
</json:item>
<json:item>
<name>U Ehrt</name>
</json:item>
</author>
<host>
<volume>78</volume>
<pages>
<last>42</last>
<first>36</first>
</pages>
<author></author>
<title>J Neurol Neurosurg Psychiatry</title>
</host>
<title>Neuropsychiatric symptoms in patients with PD and dementia: frequency, profile and associated caregiver stress</title>
</json:item>
<json:item>
<author>
<json:item>
<name>B Ravina</name>
</json:item>
<json:item>
<name>K Marder</name>
</json:item>
<json:item>
<name>HH Fernandez</name>
</json:item>
</author>
<host>
<volume>22</volume>
<pages>
<last>1068</last>
<first>1061</first>
</pages>
<author></author>
<title>Mov Disord</title>
</host>
<title>Diagnostic criteria for psychosis in Parkinson's disease: report of an NINDS, NIMH work group</title>
</json:item>
<json:item>
<author>
<json:item>
<name>AF Leentjens</name>
</json:item>
<json:item>
<name>FR Verhey</name>
</json:item>
<json:item>
<name>R Lousberg</name>
</json:item>
<json:item>
<name>H Spitsbergen</name>
</json:item>
<json:item>
<name>FW Wilmink</name>
</json:item>
</author>
<host>
<volume>15</volume>
<pages>
<last>649</last>
<first>644</first>
</pages>
<author></author>
<title>Int J Geriatr Psychiatry</title>
</host>
<title>The validity of the Hamilton and Montgomery–Asberg depression rating scales as screening and diagnostic tools for depression in Parkinson's disease</title>
</json:item>
<json:item>
<author>
<json:item>
<name>M Visser</name>
</json:item>
<json:item>
<name>AF Leentjens</name>
</json:item>
<json:item>
<name>J Marinus</name>
</json:item>
<json:item>
<name>AM Stiggelbout</name>
</json:item>
<json:item>
<name>JJ van Hilten</name>
</json:item>
</author>
<host>
<volume>21</volume>
<pages>
<last>672</last>
<first>668</first>
</pages>
<author></author>
<title>Mov Disord</title>
</host>
<title>Reliability and validity of the Beck depression inventory in patients with Parkinson's disease</title>
</json:item>
<json:item>
<author>
<json:item>
<name>FS Ertan</name>
</json:item>
<json:item>
<name>T Ertan</name>
</json:item>
<json:item>
<name>G Kiziltan</name>
</json:item>
<json:item>
<name>H Uyguçgil</name>
</json:item>
</author>
<host>
<volume>76</volume>
<pages>
<last>1447</last>
<first>1445</first>
</pages>
<author></author>
<title>J Neurol Neurosurg Psychiatry</title>
</host>
<title>Reliability and validity of the Geriatric Depression Scale in depression in Parkinson's disease</title>
</json:item>
<json:item>
<author>
<json:item>
<name>D Brandstaedter</name>
</json:item>
<json:item>
<name>S Spieker</name>
</json:item>
<json:item>
<name>G Ulm</name>
</json:item>
</author>
<host>
<volume>252</volume>
<pages>
<last>1066</last>
<first>1060</first>
</pages>
<author></author>
<title>J Neurol</title>
</host>
<title>Development and evaluation of the Parkinson Psychosis Questionnaire A screening‐instrument for the early diagnosis of drug‐induced psychosis in Parkinson's disease</title>
</json:item>
<json:item>
<author>
<json:item>
<name>D Aarsland</name>
</json:item>
<json:item>
<name>M Emre</name>
</json:item>
<json:item>
<name>A Lees</name>
</json:item>
<json:item>
<name>W Poewe</name>
</json:item>
<json:item>
<name>C Ballard</name>
</json:item>
</author>
<host>
<volume>68</volume>
<pages>
<first>80</first>
</pages>
<author></author>
<title>Neurology</title>
</host>
<title>Practice parameter: evaluation and treatment of depression, psychosis, and dementia in Parkinson disease (an evidence‐based review): report of the Quality Standards Subcommittee of the American Academy of Neurology</title>
</json:item>
</refBibs>
<genre>
<json:string>review-article</json:string>
</genre>
<host>
<volume>22</volume>
<publisherId>
<json:string>MDS</json:string>
</publisherId>
<pages>
<total>11</total>
<last>2324</last>
<first>2314</first>
</pages>
<issn>
<json:string>0885-3185</json:string>
</issn>
<issue>16</issue>
<subject>
<json:item>
<value>Viewpoint</value>
</json:item>
</subject>
<genre>
<json:string>journal</json:string>
</genre>
<language>
<json:string>unknown</json:string>
</language>
<eissn>
<json:string>1531-8257</json:string>
</eissn>
<title>Movement Disorders</title>
<doi>
<json:string>10.1002/(ISSN)1531-8257</json:string>
</doi>
</host>
<categories>
<wos>
<json:string>science</json:string>
<json:string>clinical neurology</json:string>
</wos>
<scienceMetrix>
<json:string>health sciences</json:string>
<json:string>clinical medicine</json:string>
<json:string>neurology & neurosurgery</json:string>
</scienceMetrix>
</categories>
<publicationDate>2007</publicationDate>
<copyrightDate>2007</copyrightDate>
<doi>
<json:string>10.1002/mds.21844</json:string>
</doi>
<id>6E57B2447643E9AF227ECAC3B1DF8B327F449F2D</id>
<score>0.11520059</score>
<fulltext>
<json:item>
<extension>pdf</extension>
<original>true</original>
<mimetype>application/pdf</mimetype>
<uri>https://api.istex.fr/document/6E57B2447643E9AF227ECAC3B1DF8B327F449F2D/fulltext/pdf</uri>
</json:item>
<json:item>
<extension>zip</extension>
<original>false</original>
<mimetype>application/zip</mimetype>
<uri>https://api.istex.fr/document/6E57B2447643E9AF227ECAC3B1DF8B327F449F2D/fulltext/zip</uri>
</json:item>
<istex:fulltextTEI uri="https://api.istex.fr/document/6E57B2447643E9AF227ECAC3B1DF8B327F449F2D/fulltext/tei">
<teiHeader>
<fileDesc>
<titleStmt>
<title level="a" type="main" xml:lang="en">Diagnostic procedures for Parkinson's disease dementia: Recommendations from the movement disorder society task force</title>
</titleStmt>
<publicationStmt>
<authority>ISTEX</authority>
<publisher>Wiley Subscription Services, Inc., A Wiley Company</publisher>
<pubPlace>Hoboken</pubPlace>
<availability>
<p>Copyright © 2007 Movement Disorder Society</p>
</availability>
<date>2007</date>
</publicationStmt>
<sourceDesc>
<biblStruct type="inbook">
<analytic>
<title level="a" type="main" xml:lang="en">Diagnostic procedures for Parkinson's disease dementia: Recommendations from the movement disorder society task force</title>
<author xml:id="author-1">
<persName>
<forename type="first">Bruno</forename>
<surname>Dubois</surname>
</persName>
<roleName type="degree">MD</roleName>
<affiliation>INSERM‐UPMC UMRS 610, Federation of Neurology, AP‐HP, Salpêtrière Hospital; Université Paris6, Paris, France</affiliation>
<affiliation>Neurology Department and Inserm U610, Salpêtrière Hospital, 47 Bd de l'Hôpital, Paris 75013, France</affiliation>
</author>
<author xml:id="author-2">
<persName>
<forename type="first">David</forename>
<surname>Burn</surname>
</persName>
<roleName type="degree">MD</roleName>
<affiliation>Institute for Ageing and Health, Newcastle University, United Kingdom</affiliation>
</author>
<author xml:id="author-3">
<persName>
<forename type="first">Christopher</forename>
<surname>Goetz</surname>
</persName>
<roleName type="degree">MD</roleName>
<affiliation>Department of Neurological Sciences, Rush University Medical Center, Chicago, Illinois, USA</affiliation>
</author>
<author xml:id="author-4">
<persName>
<forename type="first">Dag</forename>
<surname>Aarsland</surname>
</persName>
<roleName type="degree">MD, PhD</roleName>
<affiliation>Norwegian Centre for Movement Disorders, Stavanger University Hospital, Stavanger, Norway</affiliation>
<affiliation>School of Medicine, University of Bergen, Norway</affiliation>
</author>
<author xml:id="author-5">
<persName>
<forename type="first">Richard G.</forename>
<surname>Brown</surname>
</persName>
<roleName type="degree">PhD</roleName>
<affiliation>Department of Psychology, King's College, London, United Kingdom</affiliation>
<affiliation>MRC Centre for Neurodegeneration Research, Institute of Psychiatry, King's College, London, United Kingdom</affiliation>
</author>
<author xml:id="author-6">
<persName>
<forename type="first">Gerald A.</forename>
<surname>Broe</surname>
</persName>
<roleName type="degree">HB, BS</roleName>
<affiliation>Ageing Research Centre, Prince of Wales Hospital, Randwick, New South Wales, Australia</affiliation>
<affiliation>Faculty of Medicine, Prince of Wales Medical Research Institute, University of New South Wales, Randwick, New South Wales, Australia</affiliation>
</author>
<author xml:id="author-7">
<persName>
<forename type="first">Dennis</forename>
<surname>Dickson</surname>
</persName>
<roleName type="degree">MD</roleName>
<affiliation>Department of Neuroscience, Mayo Clinic College of Medicine, Jacksonville, Florida, USA</affiliation>
</author>
<author xml:id="author-8">
<persName>
<forename type="first">Charles</forename>
<surname>Duyckaerts</surname>
</persName>
<roleName type="degree">MD, PhD</roleName>
<affiliation>Neuropathology Laboratory, Salpetriere Hospital, Paris VI Pierre et Marie Curie University, Inserm U679, Paris, France</affiliation>
</author>
<author xml:id="author-9">
<persName>
<forename type="first">Jefferey</forename>
<surname>Cummings</surname>
</persName>
<roleName type="degree">MD</roleName>
<affiliation>Department of Neurology, David Geffen School of Medicine at UCLA, Los Angeles, California, USA</affiliation>
</author>
<author xml:id="author-10">
<persName>
<forename type="first">Serge</forename>
<surname>Gauthier</surname>
</persName>
<roleName type="degree">MD</roleName>
<affiliation>Alzheimer Disease and Related Disorders Unit, McGill Center for Studies in Aging, Montreal, Quebec, Canada</affiliation>
</author>
<author xml:id="author-11">
<persName>
<forename type="first">Amos</forename>
<surname>Korczyn</surname>
</persName>
<roleName type="degree">MD, MSc</roleName>
<affiliation>Department of Neurology, Tel‐Aviv University, Ramat ‐Aviv, Israel</affiliation>
</author>
<author xml:id="author-12">
<persName>
<forename type="first">Andrew</forename>
<surname>Lees</surname>
</persName>
<roleName type="degree">FRCP</roleName>
<affiliation>Department of Neurology, The National Hospital for Neurology and Neurosurgery, Queen Square, London, United Kingdom</affiliation>
</author>
<author xml:id="author-13">
<persName>
<forename type="first">Richard</forename>
<surname>Levy</surname>
</persName>
<roleName type="degree">MD, PhD</roleName>
<affiliation>INSERM U610, Hôpital de la Salpêtrière & AP‐HP, Hôpital Saint Antoine, Service de Neurologie, Paris, France</affiliation>
</author>
<author xml:id="author-14">
<persName>
<forename type="first">Irene</forename>
<surname>Litvan</surname>
</persName>
<roleName type="degree">MD</roleName>
<affiliation>Movement Disorder Program, Department of Neurology, University of Louisville School of Medicine, Louisville, Kentucky, USA</affiliation>
</author>
<author xml:id="author-15">
<persName>
<forename type="first">Yoshikuni</forename>
<surname>Mizuno</surname>
</persName>
<roleName type="degree">MD</roleName>
<affiliation>Department of Neurology, Research Institute for Diseases of Old Ages, Juntendo University School of Medicine, Bunkyo‐ku, Tokyo, Japan</affiliation>
</author>
<author xml:id="author-16">
<persName>
<forename type="first">Ian G.</forename>
<surname>McKeith</surname>
</persName>
<roleName type="degree">MD</roleName>
<affiliation>Institute for Ageing and Health, Newcastle University, Newcastle upon Tyne, United Kingdom</affiliation>
</author>
<author xml:id="author-17">
<persName>
<forename type="first">C. Warren</forename>
<surname>Olanow</surname>
</persName>
<roleName type="degree">MD</roleName>
<affiliation>Department of Neurology, Mount Sinai School of Medicine, New York, USA</affiliation>
<affiliation>Department of Neuroscience, Mount Sinai School of Medicine, New York, USA</affiliation>
</author>
<author xml:id="author-18">
<persName>
<forename type="first">Werner</forename>
<surname>Poewe</surname>
</persName>
<roleName type="degree">MD</roleName>
<affiliation>Department of Neurology, Medical University of Innsbruck, Innsbruck, Austria</affiliation>
</author>
<author xml:id="author-19">
<persName>
<forename type="first">Cristina</forename>
<surname>Sampaio</surname>
</persName>
<roleName type="degree">MD, PhD</roleName>
<affiliation>Laboratorio de Farmacologia Clinica e Terapeutica, Faculdade de Medicina de Lisboa e Instituto de Medicina Molecular, Lisboa, Portugal</affiliation>
</author>
<author xml:id="author-20">
<persName>
<forename type="first">Eduardo</forename>
<surname>Tolosa</surname>
</persName>
<roleName type="degree">MD</roleName>
<affiliation>Parkinson's Disease and Movement Disorders Unit, Neurology Service, Institut Clinic de Neurociences, Hospital Clinic de Barcelona, IDIBAPS, Universitat de Barcelona, CIBERNED, Barcelona, Catalonia, Spain</affiliation>
</author>
<author xml:id="author-21">
<persName>
<forename type="first">Murat</forename>
<surname>Emre</surname>
</persName>
<roleName type="degree">MD</roleName>
<affiliation>Department of Neurology, Behavioral Neurology and Movement Disorders Unit, Ístanbul Faculty of Medicine, Ístanbul University, Ístanbul, Turkey</affiliation>
</author>
</analytic>
<monogr>
<title level="j">Movement Disorders</title>
<title level="j" type="abbrev">Mov. Disord.</title>
<idno type="pISSN">0885-3185</idno>
<idno type="eISSN">1531-8257</idno>
<idno type="DOI">10.1002/(ISSN)1531-8257</idno>
<imprint>
<publisher>Wiley Subscription Services, Inc., A Wiley Company</publisher>
<pubPlace>Hoboken</pubPlace>
<date type="published" when="2007-12-15"></date>
<biblScope unit="volume">22</biblScope>
<biblScope unit="issue">16</biblScope>
<biblScope unit="page" from="2314">2314</biblScope>
<biblScope unit="page" to="2324">2324</biblScope>
</imprint>
</monogr>
<idno type="istex">6E57B2447643E9AF227ECAC3B1DF8B327F449F2D</idno>
<idno type="DOI">10.1002/mds.21844</idno>
<idno type="ArticleID">MDS21844</idno>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc>
<creation>
<date>2007</date>
</creation>
<langUsage>
<language ident="en">en</language>
</langUsage>
<abstract xml:lang="en">
<p>A preceding article described the clinical features of Parkinson's disease dementia (PD‐D) and proposed clinical diagnostic criteria for “probable” and “possible” PD‐D. The main focus of this article is to operationalize the diagnosis of PD‐D and to propose pratical guidelines based on a two level process depending upon the clinical scenario and the expertise of the evaluator involved in the assessment. Level I is aimed primarily at the clinician with no particular expertise in neuropsychological methods, but who requires a simple, pragmatic set of tests that are not excessively time‐consuming. Level I can be used alone or in concert with Level II, which is more suitable when there is the need to specify the pattern and the severity on the dementia of PD‐D for clinical monitoring, research studies or pharmacological trials. Level II tests can also be proposed when the diagnosis of PD‐D remains uncertain or equivocal at the end of a Level I evaluation. Given the lack of evidence‐based standards for some tests when applied in this clinical context, we have tried to make practical and unambiguous recommendations, based upon the available literature and the collective experience of the Task Force. We accept, however, that further validation of certain tests and modifications in the recommended cut off values will be required through future studies. © 2007 Movement Disorder Society</p>
</abstract>
<textClass xml:lang="en">
<keywords scheme="keyword">
<list>
<head>keywords</head>
<item>
<term>Parkinson's disease</term>
</item>
<item>
<term>PD dementia</term>
</item>
<item>
<term>diagnostic criteria</term>
</item>
<item>
<term>executive functions</term>
</item>
<item>
<term>task force</term>
</item>
</list>
</keywords>
</textClass>
<textClass>
<keywords scheme="Journal Subject">
<list>
<head>article-category</head>
<item>
<term>Viewpoint</term>
</item>
</list>
</keywords>
</textClass>
</profileDesc>
<revisionDesc>
<change when="2007-02-12">Received</change>
<change when="2007-10-16">Registration</change>
<change when="2007-12-15">Published</change>
</revisionDesc>
</teiHeader>
</istex:fulltextTEI>
<json:item>
<extension>txt</extension>
<original>false</original>
<mimetype>text/plain</mimetype>
<uri>https://api.istex.fr/document/6E57B2447643E9AF227ECAC3B1DF8B327F449F2D/fulltext/txt</uri>
</json:item>
</fulltext>
<metadata>
<istex:metadataXml wicri:clean="Wiley, elements deleted: body">
<istex:xmlDeclaration>version="1.0" encoding="UTF-8" standalone="yes"</istex:xmlDeclaration>
<istex:document>
<component version="2.0" type="serialArticle" xml:lang="en">
<header>
<publicationMeta level="product">
<publisherInfo>
<publisherName>Wiley Subscription Services, Inc., A Wiley Company</publisherName>
<publisherLoc>Hoboken</publisherLoc>
</publisherInfo>
<doi registered="yes">10.1002/(ISSN)1531-8257</doi>
<issn type="print">0885-3185</issn>
<issn type="electronic">1531-8257</issn>
<idGroup>
<id type="product" value="MDS"></id>
</idGroup>
<titleGroup>
<title type="main" xml:lang="en" sort="MOVEMENT DISORDERS">Movement Disorders</title>
<title type="short">Mov. Disord.</title>
</titleGroup>
</publicationMeta>
<publicationMeta level="part" position="160">
<doi origin="wiley" registered="yes">10.1002/mds.v22:16</doi>
<numberingGroup>
<numbering type="journalVolume" number="22">22</numbering>
<numbering type="journalIssue">16</numbering>
</numberingGroup>
<coverDate startDate="2007-12-15">15 December 2007</coverDate>
</publicationMeta>
<publicationMeta level="unit" type="reviewArticle" position="30" status="forIssue">
<doi origin="wiley" registered="yes">10.1002/mds.21844</doi>
<idGroup>
<id type="unit" value="MDS21844"></id>
</idGroup>
<countGroup>
<count type="pageTotal" number="11"></count>
</countGroup>
<titleGroup>
<title type="articleCategory">Viewpoint</title>
<title type="tocHeading1">Viewpoint</title>
</titleGroup>
<copyright ownership="thirdParty">Copyright © 2007 Movement Disorder Society</copyright>
<eventGroup>
<event type="manuscriptReceived" date="2007-02-12"></event>
<event type="manuscriptRevised" date="2007-08-03"></event>
<event type="manuscriptAccepted" date="2007-10-16"></event>
<event type="firstOnline" date="2007-12-20"></event>
<event type="publishedOnlineFinalForm" date="2007-12-20"></event>
<event type="xmlConverted" agent="Converter:JWSART34_TO_WML3G version:2.4.7 mode:FullText source:FullText result:FullText" date="2011-02-24"></event>
<event type="xmlConverted" agent="Converter:WILEY_ML3G_TO_WILEY_ML3GV2 version:3.8.8" date="2014-02-02"></event>
<event type="xmlConverted" agent="Converter:WML3G_To_WML3G version:4.1.7 mode:FullText,remove_FC" date="2014-10-31"></event>
</eventGroup>
<numberingGroup>
<numbering type="pageFirst">2314</numbering>
<numbering type="pageLast">2324</numbering>
</numberingGroup>
<correspondenceTo>Neurology Department and Inserm U610, Salpêtrière Hospital, 47 Bd de l'Hôpital, Paris 75013, France</correspondenceTo>
<linkGroup>
<link type="toTypesetVersion" href="file:MDS.MDS21844.pdf"></link>
</linkGroup>
</publicationMeta>
<contentMeta>
<countGroup>
<count type="figureTotal" number="0"></count>
<count type="tableTotal" number="3"></count>
<count type="referenceTotal" number="70"></count>
<count type="wordTotal" number="7944"></count>
</countGroup>
<titleGroup>
<title type="main" xml:lang="en">Diagnostic procedures for Parkinson's disease dementia: Recommendations from the movement disorder society task force</title>
<title type="short" xml:lang="en">Diagnostic Procedures for PD Dementia</title>
</titleGroup>
<creators>
<creator xml:id="au1" creatorRole="author" affiliationRef="#af1" corresponding="yes">
<personName>
<givenNames>Bruno</givenNames>
<familyName>Dubois</familyName>
<degrees>MD</degrees>
</personName>
<contactDetails>
<email>bruno.dubois@psl.aphp.fr</email>
</contactDetails>
</creator>
<creator xml:id="au2" creatorRole="author" affiliationRef="#af2">
<personName>
<givenNames>David</givenNames>
<familyName>Burn</familyName>
<degrees>MD</degrees>
</personName>
</creator>
<creator xml:id="au3" creatorRole="author" affiliationRef="#af3">
<personName>
<givenNames>Christopher</givenNames>
<familyName>Goetz</familyName>
<degrees>MD</degrees>
</personName>
</creator>
<creator xml:id="au4" creatorRole="author" affiliationRef="#af4 #af5">
<personName>
<givenNames>Dag</givenNames>
<familyName>Aarsland</familyName>
<degrees>MD, PhD</degrees>
</personName>
</creator>
<creator xml:id="au5" creatorRole="author" affiliationRef="#af6 #af7">
<personName>
<givenNames>Richard G.</givenNames>
<familyName>Brown</familyName>
<degrees>PhD</degrees>
</personName>
</creator>
<creator xml:id="au6" creatorRole="author" affiliationRef="#af8 #af9">
<personName>
<givenNames>Gerald A.</givenNames>
<familyName>Broe</familyName>
<degrees>HB, BS</degrees>
</personName>
</creator>
<creator xml:id="au7" creatorRole="author" affiliationRef="#af10">
<personName>
<givenNames>Dennis</givenNames>
<familyName>Dickson</familyName>
<degrees>MD</degrees>
</personName>
</creator>
<creator xml:id="au8" creatorRole="author" affiliationRef="#af11">
<personName>
<givenNames>Charles</givenNames>
<familyName>Duyckaerts</familyName>
<degrees>MD, PhD</degrees>
</personName>
</creator>
<creator xml:id="au9" creatorRole="author" affiliationRef="#af12">
<personName>
<givenNames>Jefferey</givenNames>
<familyName>Cummings</familyName>
<degrees>MD</degrees>
</personName>
</creator>
<creator xml:id="au10" creatorRole="author" affiliationRef="#af13">
<personName>
<givenNames>Serge</givenNames>
<familyName>Gauthier</familyName>
<degrees>MD</degrees>
</personName>
</creator>
<creator xml:id="au11" creatorRole="author" affiliationRef="#af14">
<personName>
<givenNames>Amos</givenNames>
<familyName>Korczyn</familyName>
<degrees>MD, MSc</degrees>
</personName>
</creator>
<creator xml:id="au12" creatorRole="author" affiliationRef="#af15">
<personName>
<givenNames>Andrew</givenNames>
<familyName>Lees</familyName>
<degrees>FRCP</degrees>
</personName>
</creator>
<creator xml:id="au13" creatorRole="author" affiliationRef="#af16">
<personName>
<givenNames>Richard</givenNames>
<familyName>Levy</familyName>
<degrees>MD, PhD</degrees>
</personName>
</creator>
<creator xml:id="au14" creatorRole="author" affiliationRef="#af17">
<personName>
<givenNames>Irene</givenNames>
<familyName>Litvan</familyName>
<degrees>MD</degrees>
</personName>
</creator>
<creator xml:id="au15" creatorRole="author" affiliationRef="#af18">
<personName>
<givenNames>Yoshikuni</givenNames>
<familyName>Mizuno</familyName>
<degrees>MD</degrees>
</personName>
</creator>
<creator xml:id="au16" creatorRole="author" affiliationRef="#af19">
<personName>
<givenNames>Ian G.</givenNames>
<familyName>McKeith</familyName>
<degrees>MD</degrees>
</personName>
</creator>
<creator xml:id="au17" creatorRole="author" affiliationRef="#af20 #af21">
<personName>
<givenNames>C. Warren</givenNames>
<familyName>Olanow</familyName>
<degrees>MD</degrees>
</personName>
</creator>
<creator xml:id="au18" creatorRole="author" affiliationRef="#af22">
<personName>
<givenNames>Werner</givenNames>
<familyName>Poewe</familyName>
<degrees>MD</degrees>
</personName>
</creator>
<creator xml:id="au19" creatorRole="author" affiliationRef="#af23">
<personName>
<givenNames>Cristina</givenNames>
<familyName>Sampaio</familyName>
<degrees>MD, PhD</degrees>
</personName>
</creator>
<creator xml:id="au20" creatorRole="author" affiliationRef="#af24">
<personName>
<givenNames>Eduardo</givenNames>
<familyName>Tolosa</familyName>
<degrees>MD</degrees>
</personName>
</creator>
<creator xml:id="au21" creatorRole="author" affiliationRef="#af25">
<personName>
<givenNames>Murat</givenNames>
<familyName>Emre</familyName>
<degrees>MD</degrees>
</personName>
</creator>
</creators>
<affiliationGroup>
<affiliation xml:id="af1" countryCode="FR" type="organization">
<unparsedAffiliation>INSERM‐UPMC UMRS 610, Federation of Neurology, AP‐HP, Salpêtrière Hospital; Université Paris6, Paris, France</unparsedAffiliation>
</affiliation>
<affiliation xml:id="af2" countryCode="GB" type="organization">
<unparsedAffiliation>Institute for Ageing and Health, Newcastle University, United Kingdom</unparsedAffiliation>
</affiliation>
<affiliation xml:id="af3" countryCode="US" type="organization">
<unparsedAffiliation>Department of Neurological Sciences, Rush University Medical Center, Chicago, Illinois, USA</unparsedAffiliation>
</affiliation>
<affiliation xml:id="af4" countryCode="NO" type="organization">
<unparsedAffiliation>Norwegian Centre for Movement Disorders, Stavanger University Hospital, Stavanger, Norway</unparsedAffiliation>
</affiliation>
<affiliation xml:id="af5" countryCode="NO" type="organization">
<unparsedAffiliation>School of Medicine, University of Bergen, Norway</unparsedAffiliation>
</affiliation>
<affiliation xml:id="af6" countryCode="GB" type="organization">
<unparsedAffiliation>Department of Psychology, King's College, London, United Kingdom</unparsedAffiliation>
</affiliation>
<affiliation xml:id="af7" countryCode="GB" type="organization">
<unparsedAffiliation>MRC Centre for Neurodegeneration Research, Institute of Psychiatry, King's College, London, United Kingdom</unparsedAffiliation>
</affiliation>
<affiliation xml:id="af8" countryCode="AU" type="organization">
<unparsedAffiliation>Ageing Research Centre, Prince of Wales Hospital, Randwick, New South Wales, Australia</unparsedAffiliation>
</affiliation>
<affiliation xml:id="af9" countryCode="AU" type="organization">
<unparsedAffiliation>Faculty of Medicine, Prince of Wales Medical Research Institute, University of New South Wales, Randwick, New South Wales, Australia</unparsedAffiliation>
</affiliation>
<affiliation xml:id="af10" countryCode="US" type="organization">
<unparsedAffiliation>Department of Neuroscience, Mayo Clinic College of Medicine, Jacksonville, Florida, USA</unparsedAffiliation>
</affiliation>
<affiliation xml:id="af11" countryCode="FR" type="organization">
<unparsedAffiliation>Neuropathology Laboratory, Salpetriere Hospital, Paris VI Pierre et Marie Curie University, Inserm U679, Paris, France</unparsedAffiliation>
</affiliation>
<affiliation xml:id="af12" countryCode="US" type="organization">
<unparsedAffiliation>Department of Neurology, David Geffen School of Medicine at UCLA, Los Angeles, California, USA</unparsedAffiliation>
</affiliation>
<affiliation xml:id="af13" countryCode="CA" type="organization">
<unparsedAffiliation>Alzheimer Disease and Related Disorders Unit, McGill Center for Studies in Aging, Montreal, Quebec, Canada</unparsedAffiliation>
</affiliation>
<affiliation xml:id="af14" countryCode="IL" type="organization">
<unparsedAffiliation>Department of Neurology, Tel‐Aviv University, Ramat ‐Aviv, Israel</unparsedAffiliation>
</affiliation>
<affiliation xml:id="af15" countryCode="GB" type="organization">
<unparsedAffiliation>Department of Neurology, The National Hospital for Neurology and Neurosurgery, Queen Square, London, United Kingdom</unparsedAffiliation>
</affiliation>
<affiliation xml:id="af16" countryCode="FR" type="organization">
<unparsedAffiliation>INSERM U610, Hôpital de la Salpêtrière & AP‐HP, Hôpital Saint Antoine, Service de Neurologie, Paris, France</unparsedAffiliation>
</affiliation>
<affiliation xml:id="af17" countryCode="US" type="organization">
<unparsedAffiliation>Movement Disorder Program, Department of Neurology, University of Louisville School of Medicine, Louisville, Kentucky, USA</unparsedAffiliation>
</affiliation>
<affiliation xml:id="af18" countryCode="JP" type="organization">
<unparsedAffiliation>Department of Neurology, Research Institute for Diseases of Old Ages, Juntendo University School of Medicine, Bunkyo‐ku, Tokyo, Japan</unparsedAffiliation>
</affiliation>
<affiliation xml:id="af19" countryCode="GB" type="organization">
<unparsedAffiliation>Institute for Ageing and Health, Newcastle University, Newcastle upon Tyne, United Kingdom</unparsedAffiliation>
</affiliation>
<affiliation xml:id="af20" countryCode="US" type="organization">
<unparsedAffiliation>Department of Neurology, Mount Sinai School of Medicine, New York, USA</unparsedAffiliation>
</affiliation>
<affiliation xml:id="af21" countryCode="US" type="organization">
<unparsedAffiliation>Department of Neuroscience, Mount Sinai School of Medicine, New York, USA</unparsedAffiliation>
</affiliation>
<affiliation xml:id="af22" countryCode="AT" type="organization">
<unparsedAffiliation>Department of Neurology, Medical University of Innsbruck, Innsbruck, Austria</unparsedAffiliation>
</affiliation>
<affiliation xml:id="af23" countryCode="PL" type="organization">
<unparsedAffiliation>Laboratorio de Farmacologia Clinica e Terapeutica, Faculdade de Medicina de Lisboa e Instituto de Medicina Molecular, Lisboa, Portugal</unparsedAffiliation>
</affiliation>
<affiliation xml:id="af24" countryCode="ES" type="organization">
<unparsedAffiliation>Parkinson's Disease and Movement Disorders Unit, Neurology Service, Institut Clinic de Neurociences, Hospital Clinic de Barcelona, IDIBAPS, Universitat de Barcelona, CIBERNED, Barcelona, Catalonia, Spain</unparsedAffiliation>
</affiliation>
<affiliation xml:id="af25" countryCode="TR" type="organization">
<unparsedAffiliation>Department of Neurology, Behavioral Neurology and Movement Disorders Unit, Ístanbul Faculty of Medicine, Ístanbul University, Ístanbul, Turkey</unparsedAffiliation>
</affiliation>
</affiliationGroup>
<keywordGroup xml:lang="en" type="author">
<keyword xml:id="kwd1">Parkinson's disease</keyword>
<keyword xml:id="kwd2">PD dementia</keyword>
<keyword xml:id="kwd3">diagnostic criteria</keyword>
<keyword xml:id="kwd4">executive functions</keyword>
<keyword xml:id="kwd5">task force</keyword>
</keywordGroup>
<abstractGroup>
<abstract type="main" xml:lang="en">
<title type="main">Abstract</title>
<p>A preceding article described the clinical features of Parkinson's disease dementia (PD‐D) and proposed clinical diagnostic criteria for “probable” and “possible” PD‐D. The main focus of this article is to operationalize the diagnosis of PD‐D and to propose pratical guidelines based on a two level process depending upon the clinical scenario and the expertise of the evaluator involved in the assessment. Level I is aimed primarily at the clinician with no particular expertise in neuropsychological methods, but who requires a simple, pragmatic set of tests that are not excessively time‐consuming. Level I can be used alone or in concert with Level II, which is more suitable when there is the need to specify the pattern and the severity on the dementia of PD‐D for clinical monitoring, research studies or pharmacological trials. Level II tests can also be proposed when the diagnosis of PD‐D remains uncertain or equivocal at the end of a Level I evaluation. Given the lack of evidence‐based standards for some tests when applied in this clinical context, we have tried to make practical and unambiguous recommendations, based upon the available literature and the collective experience of the Task Force. We accept, however, that further validation of certain tests and modifications in the recommended cut off values will be required through future studies. © 2007 Movement Disorder Society</p>
</abstract>
</abstractGroup>
</contentMeta>
</header>
</component>
</istex:document>
</istex:metadataXml>
<mods version="3.6">
<titleInfo lang="en">
<title>Diagnostic procedures for Parkinson's disease dementia: Recommendations from the movement disorder society task force</title>
</titleInfo>
<titleInfo type="abbreviated" lang="en">
<title>Diagnostic Procedures for PD Dementia</title>
</titleInfo>
<titleInfo type="alternative" contentType="CDATA" lang="en">
<title>Diagnostic procedures for Parkinson's disease dementia: Recommendations from the movement disorder society task force</title>
</titleInfo>
<name type="personal">
<namePart type="given">Bruno</namePart>
<namePart type="family">Dubois</namePart>
<namePart type="termsOfAddress">MD</namePart>
<affiliation>INSERM‐UPMC UMRS 610, Federation of Neurology, AP‐HP, Salpêtrière Hospital; Université Paris6, Paris, France</affiliation>
<affiliation>Neurology Department and Inserm U610, Salpêtrière Hospital, 47 Bd de l'Hôpital, Paris 75013, France</affiliation>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">David</namePart>
<namePart type="family">Burn</namePart>
<namePart type="termsOfAddress">MD</namePart>
<affiliation>Institute for Ageing and Health, Newcastle University, United Kingdom</affiliation>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">Christopher</namePart>
<namePart type="family">Goetz</namePart>
<namePart type="termsOfAddress">MD</namePart>
<affiliation>Department of Neurological Sciences, Rush University Medical Center, Chicago, Illinois, USA</affiliation>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">Dag</namePart>
<namePart type="family">Aarsland</namePart>
<namePart type="termsOfAddress">MD, PhD</namePart>
<affiliation>Norwegian Centre for Movement Disorders, Stavanger University Hospital, Stavanger, Norway</affiliation>
<affiliation>School of Medicine, University of Bergen, Norway</affiliation>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">Richard G.</namePart>
<namePart type="family">Brown</namePart>
<namePart type="termsOfAddress">PhD</namePart>
<affiliation>Department of Psychology, King's College, London, United Kingdom</affiliation>
<affiliation>MRC Centre for Neurodegeneration Research, Institute of Psychiatry, King's College, London, United Kingdom</affiliation>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">Gerald A.</namePart>
<namePart type="family">Broe</namePart>
<namePart type="termsOfAddress">HB, BS</namePart>
<affiliation>Ageing Research Centre, Prince of Wales Hospital, Randwick, New South Wales, Australia</affiliation>
<affiliation>Faculty of Medicine, Prince of Wales Medical Research Institute, University of New South Wales, Randwick, New South Wales, Australia</affiliation>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">Dennis</namePart>
<namePart type="family">Dickson</namePart>
<namePart type="termsOfAddress">MD</namePart>
<affiliation>Department of Neuroscience, Mayo Clinic College of Medicine, Jacksonville, Florida, USA</affiliation>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">Charles</namePart>
<namePart type="family">Duyckaerts</namePart>
<namePart type="termsOfAddress">MD, PhD</namePart>
<affiliation>Neuropathology Laboratory, Salpetriere Hospital, Paris VI Pierre et Marie Curie University, Inserm U679, Paris, France</affiliation>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">Jefferey</namePart>
<namePart type="family">Cummings</namePart>
<namePart type="termsOfAddress">MD</namePart>
<affiliation>Department of Neurology, David Geffen School of Medicine at UCLA, Los Angeles, California, USA</affiliation>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">Serge</namePart>
<namePart type="family">Gauthier</namePart>
<namePart type="termsOfAddress">MD</namePart>
<affiliation>Alzheimer Disease and Related Disorders Unit, McGill Center for Studies in Aging, Montreal, Quebec, Canada</affiliation>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">Amos</namePart>
<namePart type="family">Korczyn</namePart>
<namePart type="termsOfAddress">MD, MSc</namePart>
<affiliation>Department of Neurology, Tel‐Aviv University, Ramat ‐Aviv, Israel</affiliation>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">Andrew</namePart>
<namePart type="family">Lees</namePart>
<namePart type="termsOfAddress">FRCP</namePart>
<affiliation>Department of Neurology, The National Hospital for Neurology and Neurosurgery, Queen Square, London, United Kingdom</affiliation>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">Richard</namePart>
<namePart type="family">Levy</namePart>
<namePart type="termsOfAddress">MD, PhD</namePart>
<affiliation>INSERM U610, Hôpital de la Salpêtrière & AP‐HP, Hôpital Saint Antoine, Service de Neurologie, Paris, France</affiliation>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">Irene</namePart>
<namePart type="family">Litvan</namePart>
<namePart type="termsOfAddress">MD</namePart>
<affiliation>Movement Disorder Program, Department of Neurology, University of Louisville School of Medicine, Louisville, Kentucky, USA</affiliation>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">Yoshikuni</namePart>
<namePart type="family">Mizuno</namePart>
<namePart type="termsOfAddress">MD</namePart>
<affiliation>Department of Neurology, Research Institute for Diseases of Old Ages, Juntendo University School of Medicine, Bunkyo‐ku, Tokyo, Japan</affiliation>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">Ian G.</namePart>
<namePart type="family">McKeith</namePart>
<namePart type="termsOfAddress">MD</namePart>
<affiliation>Institute for Ageing and Health, Newcastle University, Newcastle upon Tyne, United Kingdom</affiliation>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">C. Warren</namePart>
<namePart type="family">Olanow</namePart>
<namePart type="termsOfAddress">MD</namePart>
<affiliation>Department of Neurology, Mount Sinai School of Medicine, New York, USA</affiliation>
<affiliation>Department of Neuroscience, Mount Sinai School of Medicine, New York, USA</affiliation>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">Werner</namePart>
<namePart type="family">Poewe</namePart>
<namePart type="termsOfAddress">MD</namePart>
<affiliation>Department of Neurology, Medical University of Innsbruck, Innsbruck, Austria</affiliation>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">Cristina</namePart>
<namePart type="family">Sampaio</namePart>
<namePart type="termsOfAddress">MD, PhD</namePart>
<affiliation>Laboratorio de Farmacologia Clinica e Terapeutica, Faculdade de Medicina de Lisboa e Instituto de Medicina Molecular, Lisboa, Portugal</affiliation>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">Eduardo</namePart>
<namePart type="family">Tolosa</namePart>
<namePart type="termsOfAddress">MD</namePart>
<affiliation>Parkinson's Disease and Movement Disorders Unit, Neurology Service, Institut Clinic de Neurociences, Hospital Clinic de Barcelona, IDIBAPS, Universitat de Barcelona, CIBERNED, Barcelona, Catalonia, Spain</affiliation>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">Murat</namePart>
<namePart type="family">Emre</namePart>
<namePart type="termsOfAddress">MD</namePart>
<affiliation>Department of Neurology, Behavioral Neurology and Movement Disorders Unit, Ístanbul Faculty of Medicine, Ístanbul University, Ístanbul, Turkey</affiliation>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<typeOfResource>text</typeOfResource>
<genre type="review-article" displayLabel="reviewArticle"></genre>
<originInfo>
<publisher>Wiley Subscription Services, Inc., A Wiley Company</publisher>
<place>
<placeTerm type="text">Hoboken</placeTerm>
</place>
<dateIssued encoding="w3cdtf">2007-12-15</dateIssued>
<dateCaptured encoding="w3cdtf">2007-02-12</dateCaptured>
<dateValid encoding="w3cdtf">2007-10-16</dateValid>
<copyrightDate encoding="w3cdtf">2007</copyrightDate>
</originInfo>
<language>
<languageTerm type="code" authority="rfc3066">en</languageTerm>
<languageTerm type="code" authority="iso639-2b">eng</languageTerm>
</language>
<physicalDescription>
<internetMediaType>text/html</internetMediaType>
<extent unit="tables">3</extent>
<extent unit="references">70</extent>
<extent unit="words">7944</extent>
</physicalDescription>
<abstract lang="en">A preceding article described the clinical features of Parkinson's disease dementia (PD‐D) and proposed clinical diagnostic criteria for “probable” and “possible” PD‐D. The main focus of this article is to operationalize the diagnosis of PD‐D and to propose pratical guidelines based on a two level process depending upon the clinical scenario and the expertise of the evaluator involved in the assessment. Level I is aimed primarily at the clinician with no particular expertise in neuropsychological methods, but who requires a simple, pragmatic set of tests that are not excessively time‐consuming. Level I can be used alone or in concert with Level II, which is more suitable when there is the need to specify the pattern and the severity on the dementia of PD‐D for clinical monitoring, research studies or pharmacological trials. Level II tests can also be proposed when the diagnosis of PD‐D remains uncertain or equivocal at the end of a Level I evaluation. Given the lack of evidence‐based standards for some tests when applied in this clinical context, we have tried to make practical and unambiguous recommendations, based upon the available literature and the collective experience of the Task Force. We accept, however, that further validation of certain tests and modifications in the recommended cut off values will be required through future studies. © 2007 Movement Disorder Society</abstract>
<subject lang="en">
<genre>keywords</genre>
<topic>Parkinson's disease</topic>
<topic>PD dementia</topic>
<topic>diagnostic criteria</topic>
<topic>executive functions</topic>
<topic>task force</topic>
</subject>
<relatedItem type="host">
<titleInfo>
<title>Movement Disorders</title>
</titleInfo>
<titleInfo type="abbreviated">
<title>Mov. Disord.</title>
</titleInfo>
<genre type="journal">journal</genre>
<subject>
<genre>article-category</genre>
<topic>Viewpoint</topic>
</subject>
<identifier type="ISSN">0885-3185</identifier>
<identifier type="eISSN">1531-8257</identifier>
<identifier type="DOI">10.1002/(ISSN)1531-8257</identifier>
<identifier type="PublisherID">MDS</identifier>
<part>
<date>2007</date>
<detail type="volume">
<caption>vol.</caption>
<number>22</number>
</detail>
<detail type="issue">
<caption>no.</caption>
<number>16</number>
</detail>
<extent unit="pages">
<start>2314</start>
<end>2324</end>
<total>11</total>
</extent>
</part>
</relatedItem>
<identifier type="istex">6E57B2447643E9AF227ECAC3B1DF8B327F449F2D</identifier>
<identifier type="DOI">10.1002/mds.21844</identifier>
<identifier type="ArticleID">MDS21844</identifier>
<accessCondition type="use and reproduction" contentType="copyright">Copyright © 2007 Movement Disorder Society</accessCondition>
<recordInfo>
<recordContentSource>WILEY</recordContentSource>
<recordOrigin>Wiley Subscription Services, Inc., A Wiley Company</recordOrigin>
</recordInfo>
</mods>
</metadata>
<serie></serie>
</istex>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/ParkinsonFranceV1/Data/Istex/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001A21 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Istex/Corpus/biblio.hfd -nk 001A21 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    ParkinsonFranceV1
   |flux=    Istex
   |étape=   Corpus
   |type=    RBID
   |clé=     ISTEX:6E57B2447643E9AF227ECAC3B1DF8B327F449F2D
   |texte=   Diagnostic procedures for Parkinson's disease dementia: Recommendations from the movement disorder society task force
}}

Wicri

This area was generated with Dilib version V0.6.29.
Data generation: Wed May 17 19:46:39 2017. Site generation: Mon Mar 4 15:48:15 2024